High-dose intravenous interferon-beta in multiple sclerosis patients with high-titer neutralizing antibodies (HINABS II) – A pilot study

Autor: Hegen, H., Guger, M., Harrer, A., Hoelzl, M., Kraus, J., Skrobal, A., Schautzer, F., Schmidegg, S., Schocke, M., Deisenhammer, F.
Zdroj: In Multiple Sclerosis and Related Disorders March 2014 3(2):220-226
Databáze: ScienceDirect